TGF-beta 3 expression correlates with epithelial cell death in normal, hyperplastic and malignant prostate.

Area of Science:

• Urology
• Cell Biology
• Oncology

Background:

• Cytokines of the transforming growth factor-beta (TGF-beta) family are implicated in cellular growth control.
• Prostate homeostasis is potentially regulated by TGF-beta family members.
• TGF-beta 3 is a key cytokine in cellular regulation.

Purpose of the Study:

• To investigate the expression of TGF-beta 3 in normal prostate (NP), benign prostate hyperplasia (BPH), and prostate cancer (PCa).
• To correlate TGF-beta 3 expression with cell death and proliferation.
• To understand the role of TGF-beta 3 in prostate carcinogenesis and response to therapy.

Main Methods:

• Immunohistochemical analysis of TGF-beta 3 expression in NP, BPH, and PCa tissues.
• Double labeling techniques using terminal transferase (for cell death) and anti-Ki67 antibodies (for proliferation).
• Rat model of castration to study TGF-beta 3 expression changes.
• Analysis of human tumor samples post-hormonal ablation.

Main Results:

• TGF-beta 3 expression was detected in the basal cell layer of NP and BPH, correlating with frequent cell death.
• Proliferating cells were found in TGF-beta 3 negative areas; cell death was absent without TGF-beta 3.
• PCa exhibited high proliferation and absent cell death, with undetectable TGF-beta 3 expression.
• Castration in rats induced TGF-beta 3 expression in basal cell layers, associated with massive cell death.
• Human tumor samples after hormonal ablation showed co-existing TGF-beta 3 positive (cell death) and negative (proliferation) foci.

Conclusions:

• TGF-beta 3 expression strictly correlates with cell death in normal and hyperplastic prostate.
• The disappearance of TGF-beta 3 is indicative of high cell proliferation and the establishment of the malignant phenotype in prostate cancer.
• TGF-beta 3 may serve as a biomarker for prostate cancer progression and therapeutic response.